Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK

CONCLUSIONS: Monoclonal antibody treatments for Alzheimer's disease are likely to present a significant challenge for healthcare services to deliver in terms of the neuroimaging and treatment delivery. The data provided here allows health services to understand the potential demand and plan accordingly.PMID:38235531 | DOI:10.1192/bjp.2023.166

Source: The British Journal of Psychiatry for Mental Science - January 18, 2024 Category: Psychiatry Authors: Axel A S Laurell Ashwin V Venkataraman Tatjana Schmidt Marcella Montagnese Christoph Mueller Robert Stewart Jonathan Lewis Clare Mundell Jeremy D Isaacs Mani S Krishnan Robert Barber Timothy Rittman Benjamin R Underwood Source Type: research